Why It Matters
The University of Louisville faces a dual challenge: protecting its substantial federal research portfolio amid funding volatility, and navigating an increasingly fragmented legislative landscape on college athletics. The university’s 167 active NIH-funded projects—totaling approximately $82.5 million—face threats from budget pressures and political scrutiny of research priorities. Simultaneously, competing legislative proposals on Name, Image, and Likeness (NIL) regulations and student-athlete employment status are creating uncertainty about the future of collegiate sports regulation.
The university’s lobbying strategy reflects these dual pressures: securing stable appropriations funding while shaping federal athletics policy before competing visions become law.
By the Numbers
The University of Louisville reported $60,000 in in-house lobbying expenditures for the last quarter of 2025, continuing a sophisticated two-decade advocacy strategy. The university has spent over $5.4 million on lobbying since 2003, with its dedicated in-house team accounting for $2.1 million across 36 disclosures since May 2017.
The university employs a multi-firm strategy to maximize influence. Its in-house team handles day-to-day engagement on NIL legislation and TRIO program funding. Akin Gump Strauss Hauer & Feld LLP, hired in 2019, focuses on federal research funding and defense partnerships. Relation Strategy LLC, added in 2025, targets the FY26 appropriations process. Grizzle Co. served as the university’s longest partner from 2003 to 2019.
The Agenda
Federal appropriations and NIH research funding remain urgent given the university’s 167 active NIH-funded projects totaling approximately $82.5 million. Relevant vehicles include the House (H.R.5304) and Senate (S.2587) Labor-HHS-Education Appropriations Acts for FY2026.
The College for All Act of 2025 (H.R.3543 / S.1832), which would increase Pell Grants and reauthorize Federal TRIO Programs, is another consistent priority the university’s in-house team has explicitly advocated to preserve.
On collegiate athletics, the university monitors competing bills including the Student Athlete Fairness and Enforcement (SAFE) Act and the bipartisan College SPORTS Act as Congress debates athlete compensation and employment status.
Broader Context
Congress rejected the Trump administration’s proposed 40 percent NIH research funding cuts, with the FY2026 appropriations bill providing NIH $47.2–48.7 billion. However, thousands of grant applications were stalled by administrative action, and proposed indirect cost caps continue to create institutional uncertainty.
On athletics, the College SPORTS Act explicitly prohibits student-athlete employment status, while the SAFE Act creates uniform NIL protections nationwide. A Trump executive order directing the NLRB to clarify athlete employment status adds further regulatory uncertainty.
Meanwhile, the Pell Grant program faces a $5.5 billion funding shortfall even as expansion provisions are set to take effect July 1, 2026.
Between The Lines
The funding environment remains volatile despite Congress’s rejection of the steepest proposed cuts. Thousands of NIH grant applications were stalled for months by administrative action, and 521 documented "attacks on science" occurred in just 10 months of 2025, underscoring why sustained appropriations advocacy remains essential for research-intensive institutions.
Competitive Landscape
Louisville operates in a crowded lobbying environment. Northwestern University, the University of Minnesota System, the University of North Carolina at Chapel Hill, and the University of Oklahoma are all actively lobbying on FY26 appropriations and NIH funding. Baylor University lobbies on overlapping issues including college athletics, while Florida A&M pursues Title III and USDA research priorities.
The Bottom Line
The University of Louisville reported $60,000 in last quarter of 2025 in-house lobbying expenditures as Congress navigated contested debates over federal research funding, college athletics reform, and higher education finance.
While Congress ultimately preserved NIH funding levels, the administration’s simultaneous grant freezes and indirect cost proposals keep the environment unstable. Competing NIL proposals offer divergent paths forward on athlete compensation, and peer institutions are aggressively pursuing the same appropriations and policy outcomes—making Louisville’s sustained advocacy essential to protecting its $82.5 million research portfolio and shaping the future of collegiate athletics regulation.
Access the Legis1 platform for comprehensive political news, data, and insights.